These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 12565129)

  • 1. Correlation of oxidative stress and the loss of the nicotinic receptor alpha 4 subunit in the temporal cortex of patients with Alzheimer's disease.
    Yu WF; Nordberg A; Ravid R; Guan ZZ
    Neurosci Lett; 2003 Feb; 338(1):13-6. PubMed ID: 12565129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional distribution of nicotinic receptor subunit mRNAs in human brain: comparison between Alzheimer and normal brain.
    Hellström-Lindahl E; Mousavi M; Zhang X; Ravid R; Nordberg A
    Brain Res Mol Brain Res; 1999 Mar; 66(1-2):94-103. PubMed ID: 10095081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased protein levels of nicotinic receptor subunits in the hippocampus and temporal cortex of patients with Alzheimer's disease.
    Guan ZZ; Zhang X; Ravid R; Nordberg A
    J Neurochem; 2000 Jan; 74(1):237-43. PubMed ID: 10617125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein and mRNA levels of nicotinic receptors in brain of tobacco using controls and patients with Alzheimer's disease.
    Mousavi M; Hellström-Lindahl E; Guan ZZ; Shan KR; Ravid R; Nordberg A
    Neuroscience; 2003; 122(2):515-20. PubMed ID: 14614915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High selective expression of alpha7 nicotinic receptors on astrocytes in the brains of patients with sporadic Alzheimer's disease and patients carrying Swedish APP 670/671 mutation: a possible association with neuritic plaques.
    Yu WF; Guan ZZ; Bogdanovic N; Nordberg A
    Exp Neurol; 2005 Mar; 192(1):215-25. PubMed ID: 15698636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha4 but not alpha3 and alpha7 nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer's disease.
    Martin-Ruiz CM; Court JA; Molnar E; Lee M; Gotti C; Mamalaki A; Tsouloufis T; Tzartos S; Ballard C; Perry RH; Perry EK
    J Neurochem; 1999 Oct; 73(4):1635-40. PubMed ID: 10501210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The consequences of reducing expression of the alpha7 nicotinic receptor by RNA interference and of stimulating its activity with an alpha7 agonist in SH-SY5Y cells indicate that this receptor plays a neuroprotective role in connection with the pathogenesis of Alzheimer's disease.
    Qi XL; Nordberg A; Xiu J; Guan ZZ
    Neurochem Int; 2007; 51(6-7):377-83. PubMed ID: 17493709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of nicotinic acetylcholine receptors in Alzheimer's disease: postmortem investigations and experimental approaches.
    Wevers A; Burghaus L; Moser N; Witter B; Steinlein OK; Schütz U; Achnitz B; Krempel U; Nowacki S; Pilz K; Stoodt J; Lindstrom J; De Vos RA; Jansen Steur EN; Schröder H
    Behav Brain Res; 2000 Aug; 113(1-2):207-15. PubMed ID: 10942047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Change in nicotinic receptor subtypes in temporal cortex of Alzheimer brains.
    Nordberg A; Adem A; Hardy J; Winblad B
    Neurosci Lett; 1988 Apr; 86(3):317-21. PubMed ID: 3380323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuronal nicotinic receptor deficits in Alzheimer patients with the Swedish amyloid precursor protein 670/671 mutation.
    Marutle A; Warpman U; Bogdanovic N; Lannfelt L; Nordberg A
    J Neurochem; 1999 Mar; 72(3):1161-9. PubMed ID: 10037489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate stem cell antigen interacts with nicotinic acetylcholine receptors and is affected in Alzheimer's disease.
    Jensen MM; Arvaniti M; Mikkelsen JD; Michalski D; Pinborg LH; Härtig W; Thomsen MS
    Neurobiol Aging; 2015 Apr; 36(4):1629-1638. PubMed ID: 25680266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular expression of alpha7 nicotinic acetylcholine receptor protein in the temporal cortex in Alzheimer's and Parkinson's disease--a stereological approach.
    Banerjee C; Nyengaard JR; Wevers A; de Vos RA; Jansen Steur EN; Lindstrom J; Pilz K; Nowacki S; Bloch W; Schröder H
    Neurobiol Dis; 2000 Dec; 7(6 Pt B):666-72. PubMed ID: 11114264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotinic acetylcholine receptor immunohistochemistry in Alzheimer's disease and dementia with Lewy bodies: differential neuronal and astroglial pathology.
    Teaktong T; Graham AJ; Court JA; Perry RH; Jaros E; Johnson M; Hall R; Perry EK
    J Neurol Sci; 2004 Oct; 225(1-2):39-49. PubMed ID: 15465084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotinic receptors in dementia of Alzheimer, Lewy body and vascular types.
    Martin-Ruiz C; Court J; Lee M; Piggott M; Johnson M; Ballard C; Kalaria R; Perry R; Perry E
    Acta Neurol Scand Suppl; 2000; 176():34-41. PubMed ID: 11261803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression of ND4, a subunit of complex I of oxidative phosphorylation in mitochondria, is decreased in temporal cortex of brains of Alzheimer's disease patients.
    Fukuyama R; Hatanpää K; Rapoport SI; Chandrasekaran K
    Brain Res; 1996 Mar; 713(1-2):290-3. PubMed ID: 8725003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotinic receptors, muscarinic receptors and choline acetyltransferase activity in the temporal cortex of Alzheimer patients with differing apolipoprotein E genotypes.
    Svensson AL; Warpman U; Hellström-Lindahl E; Bogdanovic N; Lannfelt L; Nordberg A
    Neurosci Lett; 1997 Aug; 232(1):37-40. PubMed ID: 9292886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical localization of nicotinic beta2 and alpha4 receptor subunits in normal human brain and individuals with Lewy body and Alzheimer's disease: preliminary observations.
    Sparks DL; Beach TG; Lukas RJ
    Neurosci Lett; 1998 Nov; 256(3):151-4. PubMed ID: 9855362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease.
    Marcus DL; Thomas C; Rodriguez C; Simberkoff K; Tsai JS; Strafaci JA; Freedman ML
    Exp Neurol; 1998 Mar; 150(1):40-4. PubMed ID: 9514828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibiting gene expression of alpha3 nicotinic receptor in SH-SY5Y cells with the effects on APP metabolism and antioxidation in Alzheimer's disease.
    Tang Z; An Y; Qi XL; Xiao Y; Shan KR; Guan ZZ
    Neurochem Int; 2008 Nov; 53(5):112-7. PubMed ID: 18647633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective nicotinic acetylcholine receptor subunit deficits identified in Alzheimer's disease, Parkinson's disease and dementia with Lewy bodies by immunoprecipitation.
    Gotti C; Moretti M; Bohr I; Ziabreva I; Vailati S; Longhi R; Riganti L; Gaimarri A; McKeith IG; Perry RH; Aarsland D; Larsen JP; Sher E; Beattie R; Clementi F; Court JA
    Neurobiol Dis; 2006 Aug; 23(2):481-9. PubMed ID: 16759874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.